Xian-Ming Zeng obtained his Ph.D. degree in pharmaceutical sciences from King’s College London, London, UK, in 1997. He serves as a Vice President and Head of CMC's Respiratory Department of Teva Branded Pharmaceutical Products R&D, Inc., Horsham, Pa, USA. Zeng joined IVAX Diagnostics Inc., Miami, Fla, USA in 1999 as a New Product Manager and was promoted to Head of Pulmonary Research Department, where he was responsible for the pharmaceutical development of several inhalation products. He also served as a Professor of pharmaceutics, and Director of Research at Medway School of Pharmacy, the Universities of Greenwich and Kent, Kent, UK. Zeng published peer-reviewed research papers and review articles on novel drug delivery systems particularly inhalation technologies. He is also a co-author of three textbooks and a co-inventor of a number of patents and patent applications for novel formulation, device, and manufacturing technologies for inhalation products. Zeng is a Board Member of International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS).
Biography Updated on 6 June 2012